Bone marrow transplantation for infantile malignant osteopetrosis
- PMID: 7583393
- DOI: 10.1097/00043426-199511000-00013
Bone marrow transplantation for infantile malignant osteopetrosis
Abstract
Purpose: Most patients diagnosed with malignant osteopetrosis die during infancy or early childhood from hemorrhage and infection due to bone marrow failure. Allogeneic bone marrow transplantation (BMT) has been reported to provide curative therapy for this disorder. We report our experience with eight patients with malignant osteopetrosis who underwent BMT.
Patients and methods: Between May 1987 and August 1992, eight children with malignant osteopetrosis underwent allogeneic BMT. Median age at BMT was 9 months (range, 2-36 months). Six patients received marrow from HLA-identical sibling donors, one from phenotypically matched father, and one from a one antigen mismatched father. BMT conditioning for all patients was busulfan 16 mg/kg and cyclophosphamide 200 mg/kg each administered over 4 days. Graft versus host disease (GVHD) prophylaxis included cyclosporin A in six patients or cyclosporin A and methotrexate in two patients.
Results: Six patients, including those who received bone marrow from their father's, engrafted as documented by bone marrow biopsy showing an increase in osteoclasts in all cases and by chromosomal analysis in four patients. Two patients died without engraftment. Three out of six patients engrafted are alive and well at the follow-up of 48, 63, and 81 months. Serum calcium, alkaline, and acid phosphatase levels normalized within 2 months. These patients have full bone marrow reconstitution. Serial radiologic studies revealed bone marrow remodelling and a new nonsclerotic bone formation. Vision improved dramatically in the youngest patient.
Conclusion: BMT offers cure to patients with malignant osteopetrosis with reconstitution of bone marrow and correction of metabolic disturbances. In our experience, reversibility in neurosensory deficit is possible when BMT is done at an early age.
Similar articles
-
Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.J Pediatr. 1994 Dec;125(6 Pt 1):896-902. doi: 10.1016/s0022-3476(05)82004-9. J Pediatr. 1994. PMID: 7996361 Clinical Trial.
-
[Allogeneic stem cell transplantation for 8 patients with malignant infantile osteopetrosis in China].Zhonghua Er Ke Za Zhi. 2012 Nov;50(11):807-12. Zhonghua Er Ke Za Zhi. 2012. PMID: 23302608 Chinese.
-
Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation.Bone Marrow Transplant. 2000 Jul;26(2):219-24. doi: 10.1038/sj.bmt.1702491. Bone Marrow Transplant. 2000. PMID: 10918435
-
Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation.Pediatr Transplant. 1999;3 Suppl 1:102-7. doi: 10.1034/j.1399-3046.1999.00063.x. Pediatr Transplant. 1999. PMID: 10587979 Review.
-
Osteopetrosis ('marble bone' disease).Am Fam Physician. 1993 Jan;47(1):175-80. Am Fam Physician. 1993. PMID: 8418580 Review.
Cited by
-
Radiography of successful bone marrow transplantation for osteopetrosis.Skeletal Radiol. 2007 Jun;36 Suppl 1:S34-7. doi: 10.1007/s00256-006-0141-1. Epub 2006 Jun 24. Skeletal Radiol. 2007. PMID: 16799785
-
Importance of neurological assessment before bone marrow transplantation for osteopetrosis.Arch Dis Child. 1999 Mar;80(3):273-4. doi: 10.1136/adc.80.3.273. Arch Dis Child. 1999. PMID: 10325711 Free PMC article.
-
Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.Cureus. 2022 Jul 6;14(7):e26600. doi: 10.7759/cureus.26600. eCollection 2022 Jul. Cureus. 2022. PMID: 35936184 Free PMC article. Review.
-
Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.Endocrine. 1999 Dec;11(3):309-19. doi: 10.1385/ENDO:11:3:309. Endocrine. 1999. PMID: 10786828
-
Malignant infantile osteopetrosis presenting with neonatal hypocalcaemia.Arch Dis Child Fetal Neonatal Ed. 2000 Jul;83(1):F21-3. doi: 10.1136/fn.83.1.f21. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10873166 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials